Solriamfetol may be an effective alternative for managing AD

Although several medications are approved to treat attention-deficit/hyperactivity disorder (ADHD), some individuals experience limited benefits from the drugs or develop side effects from their use.

Related Keywords

Massachusetts , United States , Maura Disalvo , Lily Ramsey , Nora Horick , Daniel Kaufman , Danielm Walsh , Craigbh Surman , Professor Of Psychiatry At Harvard Medical School , Research Program In Adult , Jazz Pharmaceuticals , Clinical Psychiatry , Massachusetts General Hospital , Mass General Brigham , Symptom Rating Scale , Clinical Global Impressions , Behavior Rating Inventory , Executive Function Adult Form , Pittsburgh Sleep Quality Index , Research Program , Associate Professor , Harvard Medical , Chloe Hutt Vater , Clinical Trial , Rain , Dopamine , Drugs , Hospital , Hyperactivity , Medical School , Narcolepsy , Norepinephrine , Obstructive Sleep Apnea , Pharmaceuticals , Placebo , Sychiatry , Research , Sleep , Sleep Apnea , Herapeutics ,